Transaction #34177 · Form 4 · 0001213900-26-111385
Niki BioSolutions, Inc. · Stock award · Stock Options
Niki BioSolutions, Inc. · Transacted July 22, 2026 · Filed October 21, 2026
What does this filing report?
An SEC Form 4 filing for Niki BioSolutions, Inc. records a stock award involving Stock Options on July 22, 2026. The reported quantity was 8,000. The filing date is October 21, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Niki BioSolutions, Inc.
- Company CIK
- 0001734005
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 8,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 8,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 21, 2026, 4:51 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Philips Laura A ↗
Director
CIK 0001401312
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 8,000
- Conversion / exercise price
- 8.83
- Exercise date
- Not reported
- Expiration date
- July 22, 2036
Filing footnotes & remarks
- F1
- The options vest as follows: (i) 2,000 options vested immediately upon the closing of the merger; and (ii) the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.